These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29208578)

  • 1. Endeavours to define optimal antithrombotic therapy after percutaneous coronary intervention.
    Kimura T
    EuroIntervention; 2017 Dec; 13(12):e1386-e1391. PubMed ID: 29208578
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice?
    Cuisset T; Capodanno D
    EuroIntervention; 2018 May; 14(1):19-23. PubMed ID: 29786540
    [No Abstract]   [Full Text] [Related]  

  • 3. The Management of Antiplatelet and Antithrombotic Regimens in Patients With Mechanical Valves Undergoing Percutaneous Coronary Intervention: A Forgotten Cohort?
    McCarthy CP; Verma S; Bhatt DL
    JAMA Cardiol; 2017 Jul; 2(7):713-714. PubMed ID: 28445573
    [No Abstract]   [Full Text] [Related]  

  • 4. And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
    Rubboli A
    Eur J Intern Med; 2019 Jul; 65():1-3. PubMed ID: 31130303
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].
    Liu HW; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):108-110. PubMed ID: 33611894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of antithrombotic therapy with new oral anticoagulants in patients with atrial fibrillation after percutaneous coronary intervention.
    Siddiqi R; Yamani N; Alnaimat S; Khurshid A; Siddiqui S; Khan MS; Khan SU
    Eur J Prev Cardiol; 2020 Dec; 27(19):2119-2122. PubMed ID: 31349774
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Antithrombotic Therapy: Beyond Coronary Artery Disease.
    Mystakidi VC; Oikonomou E; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2683-2685. PubMed ID: 32586236
    [No Abstract]   [Full Text] [Related]  

  • 8. Contributors to survival benefit of dual versus single antithrombotic therapy in chronic coronary syndrome: Survival benefit of dual antithrombotic therapy in CCS.
    Patti G; Sticchi A; Pasceri V
    Eur J Intern Med; 2020 Feb; 72():97-98. PubMed ID: 31704163
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic Therapy in Percutaneous Coronary Intervention.
    Yang X; Ghobrial J; Pinto DS
    Interv Cardiol Clin; 2016 Apr; 5(2):239-247. PubMed ID: 28582207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease].
    Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):429-431. PubMed ID: 35589590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation.
    Mallikarjuna Rao Edupuganti M; Marmagkiolis K; Cilingiroglu M; Uretsky BF; Hakeem A
    Cardiovasc Revasc Med; 2014; 15(8):414-20. PubMed ID: 25204491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!
    Vranckx P; Valgimigli M
    EuroIntervention; 2022 Jul; 18(4):e267-e268. PubMed ID: 35866255
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention.
    Agarwal N; Mahtta D; Rambarat CA; Elgendy I; Mahmoud AN
    Biomed Res Int; 2018; 2018():5690640. PubMed ID: 29770334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Things We Do for No Reason™: Routine use of triple anticoagulant therapy in patients with both nonvalvular atrial fibrillation and percutaneous coronary intervention.
    Garst C; Pitliya A; Iannetti M; Caccamo M
    J Hosp Med; 2022 Nov; 17(11):917-920. PubMed ID: 35527539
    [No Abstract]   [Full Text] [Related]  

  • 17. Almanac 2013: stable coronary artery disease.
    Islam S; Timmis A
    Wien Klin Wochenschr; 2013 Dec; 125(23-24):776-83. PubMed ID: 24297269
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    Rodriguez F; Harrington RA
    N Engl J Med; 2021 Feb; 384(5):452-460. PubMed ID: 33534976
    [No Abstract]   [Full Text] [Related]  

  • 19. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple antithrombotic therapy for atrial fibrillation and coronary stents.
    Shmyr D; Van der Merwe V; Yakiwchuk E; Barry A; Kosar L
    Can Fam Physician; 2017 May; 63(5):375-381. PubMed ID: 28500198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.